- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-14-0000271

Crinat Pharmaceuticals Private Limited
About Crinat Pharmaceuticals Private Limited
Data last updated:
Crinat Pharmaceuticals Private Limited is a private limited company based in Namakkal, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U24230TZ2020PTC033975. Its GSTIN is 33AAICC7737P1Z2 (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10,000. It is led by directors Rajan Mohan Kumar and Venkadasalam Mukesh.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Door No. 2/44 Nachan Kadu Kuttaladam Patty, Namakkal, Tamil Nadu, India – 636301.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.89 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net loss of ₹1.78 Lakh (net margin -12.8%) and EBITDA of ₹2.97 Lakh (EBITDA margin 21.4%). Revenue has grown at a compounded annual rate (CAGR) of 281% over three years.
Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
Crinat Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-14-0000271).
Company details
Recognitions & Rankings of Crinat Pharmaceuticals
Contact details
Crinat Pharmaceuticals Private Limited's registered office is in Namakkal, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressDoor No. 2/44 Nachan Kadu Kuttaladam Patty, Namakkal, Tamil Nadu, India – 636301
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Crinat Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Crinat Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Crinat Pharmaceuticals Private Limited, buy the company report.
Financials of Crinat Pharmaceuticals Private Limited
FY 2025 filings availableCrinat Pharmaceuticals Private Limited reported revenue of ₹13.89 Lakh (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 3% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 281%. EBITDA rose 76% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.97 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.78 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.4% | ||||
| Net Profit Margin | -12.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Crinat Pharmaceuticals Private Limited, buy the company report.
Board of directors of Crinat Pharmaceuticals Private Limited
Crinat Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajan Mohan Kumar | Director | 26 Jun 2020 | 6 Years 4 Months | Current |
| Venkadasalam Mukesh | Director | 26 Jun 2020 | 6 Years 4 Months | Current |
Peer comparison
Crinat Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Human Rise Pharma Private Limited | ₹13.92 Lakh (FY 2025) | -15.0% | Delhi, India | |||
| Uniway Pharmaceuticals Private Limited | ₹13.91 Lakh (FY 2018) | -55.0% | Patna, Bihar, India | |||
| Biovams Pharmaceuticals Private Limited | ₹13.9 Lakh (FY 2025) | -87.0% | Ahmedabad, Gujarat, India | |||
| Crinat Pharmaceuticals Private Limitedthis company | ₹13.89 Lakh (FY 2025) | -₹1.78 Lakh | -12.8% | -3.0% | Namakkal, Tamil Nadu, India | |
| Decorum Pharmaceuticals Private Limited | ₹13.87 Lakh (FY 2024) | -5.0% | Patna, Bihar, India |
To see the full peer comparison of Crinat Pharmaceuticals Private Limited, buy the company report.
Legal cases
Crinat Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Crinat Pharmaceuticals. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Salem, Tamil Nadu | Criminal case | Filed by the company against an individual | Pending |
To see the full case history of Crinat Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Crinat Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Crinat Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAICC7737P1Z2 | Tamil Nadu | Active | 03 Jul 2020 |
To see the full GST registrations and return filing status of Crinat Pharmaceuticals Private Limited, buy the company report.
Recent activity
Crinat Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Rajan Mohan Kumar was appointed as Director on 26 Jun 2020.
Frequently asked questions
Crinat Pharmaceuticals is an active private limited company based in Namakkal, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 June 2020 (6+ years old) and is registered under CIN U24230TZ2020PTC033975.
Crinat Pharmaceuticals has 2 current directors:
- Rajan Mohan Kumar - Director
- Venkadasalam Mukesh - Director
The latest financial statements of Crinat Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Crinat Pharmaceuticals is 33AAICC7737P1Z2, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Crinat Pharmaceuticals is U24230TZ2020PTC033975. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Crinat Pharmaceuticals has 1 court case on record: 1 filed by the company. 1 is pending.
Crinat Pharmaceuticals was incorporated on 26 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Coimbatore.
The peers of Crinat Pharmaceuticals by revenue are Human Rise Pharma Private Limited, Uniway Pharmaceuticals Private Limited, Biovams Pharmaceuticals Private Limited, Decorum Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Rajan Mohan Kumar was appointed as Director on 26 Jun 2020. Venkadasalam Mukesh was appointed as Director on 26 Jun 2020.
Yes, Crinat Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-14-0000271).
The registered office of Crinat Pharmaceuticals is at Door No. 244 Nachan Kadu Kuttaladam Patty, Namakkal, Tamil Nadu, India – 636301.

